Categories: All postsAnalysts

Paradigm lowers target on BSM Technologies, keeps “Buy” rating

BSM Technologies CEO Aly Rahemtulla.

An increased level of investment in sales, marketing and R&D will impact BSM Technologies’ (BSM Technologies Stock Quote, Chart, News: TSXV:GPS) EBITDA margins, says Paradigm Capital analyst Gabriel Leung.

In a research update to clients yesterday, Leung maintained his “Buy” rating on BSM, but lowered his one-year target on the stock from $3.00 to $2.75. The analyst’s new price target implied a return of 67% at the time of publication.

Leung says that while he is maintaining his fiscal 2015 revenue forecast of $34.6-million, he is lowering his expectation on EBITDA margins from 22.8% to 15.5%. He says this actions reflects his view that “the company will likely increase investments in key operating areas, such as sales and marketing and R&D”.

The analyst says he remains bullish on BSM because of a growing backlog of enterprise customers, its strong vertical focus, and what he says are initial signs of cross-selling activity. He notes that the telematics space is a particularly acquisitive one and thinks BSM is a potential takeout target.

In BSM’s upcoming fourth quarter, Leung expects the company will generate EBITDA of $946,000 on revenue of $7.4-million, with 12.8% EBITDA margins.

At press time, shares of BSM Technologies were up 1.2% to $1.70.

More Cantech Analysts

Tagged with: gps
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

19 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

19 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

19 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

19 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

19 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

19 hours ago